Improving pharmacovigilance: How data-driven solutions are improving drug safety
Traditional pharmacovigilance has often been slow, reactive and dependent on manual reporting. Can innovative, data-driven solutions leveraging AI, machine learning and real-world data accelerate the detection of adverse effects, from clinical trial phase to post-market surveillance?
